Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1966 Aug 6;2(5509):321–327. doi: 10.1136/bmj.2.5509.321

Allopurinol in treatment of gout.

J T Scott, A P Hall, R Grahame
PMCID: PMC1943105  PMID: 5920652

Full text

PDF
321

Images in this article

323Fig. 1
on p.323

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DELBARRE F., AUSCHER C., LABROUSSE C., GERYA D. E. LE TRAITEMENT DE LA DYSPURINIE GOUTTEUSE PAR LES PARAM'ETABOLITES ET, NOTAMMENT, PAR UN INHIBITEUR DE LA XANTHINE-OXYDASE. Presse Med. 1965 May 1;73:1275–1279. [PubMed] [Google Scholar]
  2. DENMAN A. M., HUBER H., WOOD P. H., SCOTT J. T. RETICULOCYTE COUNT IN PATIENTS WITH RHEUMATOID ARTHRITIS, WITH OBSERVATIONS ON THE EFFECT OF GOLD THERAPY ON BONE MARROW FUNCTION. Ann Rheum Dis. 1965 May;24:278–284. doi: 10.1136/ard.24.3.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DENT C. E., PHILPOT G. R. Xanthinuria, an inborn error (or deviation) of metabolism. Lancet. 1954 Jan 23;266(6804):182–185. doi: 10.1016/s0140-6736(54)91257-x. [DOI] [PubMed] [Google Scholar]
  4. DICKINSON C. J., SMELLIE J. M. Xanthinuria. Br Med J. 1959 Dec 5;2(5161):1217–1221. doi: 10.1136/bmj.2.5161.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DeConti R. C., Calabresi P. Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. N Engl J Med. 1966 Mar 3;274(9):481–486. doi: 10.1056/NEJM196603032740902. [DOI] [PubMed] [Google Scholar]
  6. ENGELMAN K., WATTS R. W., KLINENBERG J. R., SJOERDSMA A., SEEGMILLER J. E. CLINICAL, PHYSIOLOGICAL AND BIOCHEMICAL STUDIES OF A PATIENT WITH XANTHINURIA AND PHEOCHROMOCYTOMA. Am J Med. 1964 Dec;37:839–861. doi: 10.1016/0002-9343(64)90128-7. [DOI] [PubMed] [Google Scholar]
  7. FERRIS T. F., MORGAN W. S., LEVITIN H. Nephrotic syndrome caused by probenecid. N Engl J Med. 1961 Aug 24;265:381–383. doi: 10.1056/NEJM196108242650807. [DOI] [PubMed] [Google Scholar]
  8. GOLDFINGER S., KLINENBERG J. R., SEEGMILLER J. E. THE RENAL EXCRETION OF OXYPURINES. J Clin Invest. 1965 Apr;44:623–628. doi: 10.1172/JCI105175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HALL A. P., HOLLOWAY V. P., SCOTT J. T. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS. Ann Rheum Dis. 1964 Nov;23:439–446. doi: 10.1136/ard.23.6.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Houpt J. B. The effect of allopurinol (HPP) in the treatment of gout. Arthritis Rheum. 1965 Oct;8(5):899–904. doi: 10.1002/art.1780080455. [DOI] [PubMed] [Google Scholar]
  11. KLINENBERG J. R., GOLDFINGER S. E., SEEGMILLER J. E. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT. Ann Intern Med. 1965 Apr;62:639–647. doi: 10.7326/0003-4819-62-4-639. [DOI] [PubMed] [Google Scholar]
  12. METCALFE-GIBSON A., MCCALLUM F. M., MORRISON R. B., WRONG O. URINARY EXCRETION OF HYDROGEN ION IN PATIENTS WITH URIC ACID CALCULI. Clin Sci. 1965 Apr;28:325–342. [PubMed] [Google Scholar]
  13. Powell L. W., Emmerson B. T. Haemosiderosis associated with xanthine oxidase inhibition. Lancet. 1966 Jan 29;1(7431):239–240. doi: 10.1016/s0140-6736(66)90056-0. [DOI] [PubMed] [Google Scholar]
  14. REYNOLDS E. S., SCHLANT R. C., GONICK H. C., DAMMIN G. J. Fatal massive necrosis of the liver as a manifestation of hypersensitivity to probenecid. N Engl J Med. 1957 Mar 28;256(13):592–596. doi: 10.1056/NEJM195703282561304. [DOI] [PubMed] [Google Scholar]
  15. Rapado Errazti A. El Allopurinol (HPP) en el tratamiento de la enfermedad gotosa y en la hiperuricemia secundaria a diuréticos tiazídicos. Rev Clin Esp. 1965 Jul 31;98(2):133–137. [PubMed] [Google Scholar]
  16. Rundles R. W., Metz E. N., Silberman H. R. Allopurinol in the treatment of gout. Ann Intern Med. 1966 Feb;64(2):229–258. doi: 10.7326/0003-4819-64-2-229. [DOI] [PubMed] [Google Scholar]
  17. SEEGMILLER J. E., HOWELL R. R. The old and new concepts of acute gouty arthritis. Arthritis Rheum. 1962 Dec;5:616–623. doi: 10.1002/art.1780050610. [DOI] [PubMed] [Google Scholar]
  18. Smyth C. J. Studies with allopurinol (HPP) in patients with tophaceous gout. Arthritis Rheum. 1965 Oct;8(5):907–910. doi: 10.1002/art.1780080457. [DOI] [PubMed] [Google Scholar]
  19. Watts R. W., Watkins P. J., Matthias J. Q., Gibbs D. A. Allopurinal and acute uric acid nephropathy. Br Med J. 1966 Jan 22;1(5481):205–208. doi: 10.1136/bmj.1.5481.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. YUE T. F., GUTMAN A. B. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. Am J Med. 1964 Dec;37:885–898. doi: 10.1016/0002-9343(64)90131-7. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES